186 related articles for article (PubMed ID: 18777594)
21. [Effect of survivin antisense oligodeoxynucleotide on carcinoma of larynx in vivo and in vitro].
Xiang C; Liu WS; Jia SS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jan; 41(1):60-4. PubMed ID: 16646247
[TBL] [Abstract][Full Text] [Related]
22. [Effect of vascular endothelial growth factor antisense oligodeoxynucleotides on angiogenesis in lymphoma of nude mice].
Tong YJ; Zhang M; Zou P; Guo R; Yuan YH
Ai Zheng; 2005 Jan; 24(1):62-6. PubMed ID: 15642202
[TBL] [Abstract][Full Text] [Related]
23. [Experimental study of antisense oligodeoxynucleotide targeting survivin gene for cisplatin resistant human lung adeno-carcinoma xenograft in nude mice].
Zhang MC; Hu CP; Chen Q; Xia Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):717-22. PubMed ID: 17062938
[TBL] [Abstract][Full Text] [Related]
24. [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis].
Li K; Li MJ; He T; Zheng Z; Zheng XL; Qu BH; Wang Y; Duan X; Zheng YJ
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2386-90. PubMed ID: 20137690
[TBL] [Abstract][Full Text] [Related]
25. [Effect of antisurvivin oligodeoxynucleotides on proliferation and apoptosis in gastric cancer cell line BGC-823 and the molecular mechanism].
Li Y; Fan LQ; Sun Y; Zhao Q; Tan BB; Liu Y
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):265-9. PubMed ID: 21575496
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status.
Ii M; Li H; Adachi Y; Yamamoto H; Ohashi H; Taniguchi H; Arimura Y; Carbone DP; Imai K; Shinomura Y
Clin Cancer Res; 2011 Aug; 17(15):5048-59. PubMed ID: 21642381
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 antisense oligodexoyneucleotides inhibits growth and enhances chemosensitivity in gastric carcinoma cells.
Shuai XM; Han GX; Wang GB; Chen JH
World J Gastroenterol; 2006 Mar; 12(11):1766-9. PubMed ID: 16586549
[TBL] [Abstract][Full Text] [Related]
29. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
Tang GS; Cai JM; Ni J; Xiang YS; Cui JG; Zhu D; Dong JR
Ai Zheng; 2006 Mar; 25(3):269-74. PubMed ID: 16536977
[TBL] [Abstract][Full Text] [Related]
30. [Survivin antisense oligodeoxynucleotides inhibits the proliferation of hepatocellular carcinoma cells and enhances 5-FU sensitivity].
Wu FY; Huang GS; Jiang JW; Wang F; Xu XD; Peng DY
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):304-7. PubMed ID: 20159707
[TBL] [Abstract][Full Text] [Related]
31. [Inhibition of cell growth and target gene expression of human pancreatic carcinoma cells by modified antisense oligodeoxynucleotide].
Liu T; Wang Z; Zhang L
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):147-51. PubMed ID: 10072855
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligodeoxynucleotides targeting the serine/threonine kinase Pim-2 inhibited proliferation of DU-145 cells.
Dai JM; Zhang SQ; Zhang W; Lin RX; Ji ZZ; Wang SQ
Acta Pharmacol Sin; 2005 Mar; 26(3):364-8. PubMed ID: 15715935
[TBL] [Abstract][Full Text] [Related]
33. [Inhibition of A549 cells by polybutylcyanoacrylate nanoparticles loaded with antisense oligodeoxynucleotide of hTERT mRNA].
Zhang YY; Fu CJ; Zhang ZZ
Yao Xue Xue Bao; 2006 May; 41(5):446-51. PubMed ID: 16848322
[TBL] [Abstract][Full Text] [Related]
34. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes.
Kita K; Saito S; Morioka CY; Watanabe A
Int J Cancer; 1999 Feb; 80(4):553-8. PubMed ID: 9935156
[TBL] [Abstract][Full Text] [Related]
36. [Effect of hTERT ASODN on the oncogenicity and the inductive apoptosis of HL-60 cells].
Sun L; Wang F; Sun H; Le XP; Ge XF; Liu LX; Zhang QX
Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):386-9. PubMed ID: 17147228
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
38. Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
Schillaci R; Salatino M; Cassataro J; Proietti CJ; Giambartolomei GH; Rivas MA; Carnevale RP; Charreau EH; Elizalde PV
J Immunol; 2006 Mar; 176(6):3426-37. PubMed ID: 16517711
[TBL] [Abstract][Full Text] [Related]
39. [Combinative effects of FAP-1 antisense oligonucleotide and carboplatin on apoptosis of ovarian cancer cell SKOV3].
Wang B; Zheng WG; Xin XY; Qi RY; Yu YC; Cao YX
Ai Zheng; 2004 Aug; 23(8):885-9. PubMed ID: 15301708
[TBL] [Abstract][Full Text] [Related]
40. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
